HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a lower dose of transplant drug boost quality of life for older blood cancer patients?
Disease control Recruiting nowThis study is for adults aged 60 and older with blood cancers who need a stem cell transplant. It compares a standard dose of a drug (cyclophosphamide) to a lower dose, both given after transplant to prevent graft-versus-host disease (GVHD), a common complication. The main goal i…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New pill HMPL-506 shows promise in early blood cancer trial
Disease control Recruiting nowThis study tests a new oral drug, HMPL-506, in about 132 adults with certain blood cancers (like leukemia) that have come back or not responded to treatment. The main goals are to check the drug's safety and find the right dose. Researchers will also look at whether the drug help…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 01, 2026 15:58 UTC